Corium International Priced, Nasdaq: CORI
Commercial-stage pharmaceutical company focused on transdermal drug delivery.
Industry: Health Care
First Day Return: 0.0%
CORI
Commercial-stage pharmaceutical company focused on transdermal drug delivery.
| IPO Data | |
|---|---|
| IPO Date | 04/02/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $52 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Menlo Park, CA, United States |
| Founded | 1995 |
| Employees at IPO | 243 |
| Website www.coriumgroup.com | |
IPO News for Corium International
Corium International (CORI) Performance
